These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10732567)

  • 1. Budget busters.
    Cresswell J
    Community Nurse; 1999 Oct; 5(9):10. PubMed ID: 10732567
    [No Abstract]   [Full Text] [Related]  

  • 2. Pressure point. When coughing up is essential.
    Cooper C
    Health Serv J; 2000 Nov; 110(5733):suppl 1. PubMed ID: 11138527
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharma focus. Puff adders.
    Chapman S
    Health Serv J; 2003 Nov; 113(5883):suppl 6-7. PubMed ID: 14671867
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucotriene receptor antagonists for asthma can save millions, says NICE.
    Wise J
    BMJ; 2016 Dec; 355():i6835. PubMed ID: 28031161
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.
    O'Neill S; Sweeney J; Patterson CC; Menzies-Gow A; Niven R; Mansur AH; Bucknall C; Chaudhuri R; Thomson NC; Brightling CE; O'Neill C; Heaney LG;
    Thorax; 2015 Apr; 70(4):376-8. PubMed ID: 24917087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic realities and the health plight of Americans.
    Wolf BL
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):170-1. PubMed ID: 26231466
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
    Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
    J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV; Gel'tser BI; Shestovskaia TN
    Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
    [No Abstract]   [Full Text] [Related]  

  • 10. Barriers to effective pediatric asthma care.
    Swartz MK; Banasiak NC; Meadows-Oliver M
    J Pediatr Health Care; 2005; 19(2):71-9. PubMed ID: 15750551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath-actuated inhaler uses 23% less medication.
    Health Care Cost Reengineering Rep; 1998 Aug; 3(8):127-8. PubMed ID: 10182726
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost effectiveness of BDP/formoterol fixed vs. two single inhalers in the treatment of bronchial asthma].
    Kardos P; Brüggenjürgen B; Ezzat N; Buhl R
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():102-5. PubMed ID: 21595154
    [No Abstract]   [Full Text] [Related]  

  • 13. Revisiting the cost-effectiveness of omalizumab.
    Campbell JD; Spackman DE; Sullivan SD
    Allergy; 2007 Dec; 62(12):1469. PubMed ID: 17983382
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Campbell, Spackman, Sullivan letter to Allergy.
    Brown R; Turk F; Dale P; Bousquet J
    Allergy; 2008 Jun; 63(6):783. PubMed ID: 18445194
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
    Lage MJ; Gross GN; Brewster C; Spalitto A
    Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The misuse of asthma drugs.
    Colice GL
    Expert Rev Respir Med; 2013 Jun; 7(3):307-20. PubMed ID: 23734651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pharmacoeconomics of asthma].
    Plaza Moral V
    Arch Bronconeumol; 1999 May; 35 Suppl 3():22-6. PubMed ID: 10410220
    [No Abstract]   [Full Text] [Related]  

  • 18. [How to make easier the treatment of asthma].
    Ait-Khaled N
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S76-10S79. PubMed ID: 17127972
    [No Abstract]   [Full Text] [Related]  

  • 19. U.S. asthma drug costs to jump 50% by 2023.
    Manag Care; 2014 Oct; 23(10):49. PubMed ID: 26023688
    [No Abstract]   [Full Text] [Related]  

  • 20. Mepolizumab (Nucala) for severe eosinophilic asthma.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):11-2. PubMed ID: 26761344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.